{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-000970","form_type":"8-K","ticker":"UFPT","cik":"0000914156","company_name":"UFP TECHNOLOGIES INC","filed_at":"2024-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.270479+00:00","generated_at":"2026-06-05T16:20:42.110117+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"UFP Technologies reports record 2023; EPS up 7% to $5.83, sales +13.1%","bullets":["FY2023 net sales $400.1M (+13.1% YoY); net income $44.9M ($5.83 diluted EPS) vs $41.8M ($5.45).","Q4 sales $101.5M (+11.2%); net income $11.6M ($1.51) vs $8.5M ($1.10) year ago.","MedTech sales grew 21% to $346.4M; adjusted operating income +37.9% to $61.3M.","Adjusted net income per diluted share up 41.0% for full year; adjusted EBITDA $77.3M.","Added 70% capacity for robotic surgery with new clean rooms in Ireland, Costa Rica, Dominican Republic."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-000970","json":"https://secwatch.observer/filing/0001171843-24-000970.json","markdown":"https://secwatch.observer/filing/0001171843-24-000970.md","text":"https://secwatch.observer/filing/0001171843-24-000970.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/914156/000117184324000970/0001171843-24-000970-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/914156/000117184324000970/f8k_022324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T16:20:42.110117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"89b0c676866a6871b1a3304d5268406437850ff7","claim":"UFP TECHNOLOGIES INC reported fourth quarter ended December 31, 2023 results: revenue $101.5 million, net income $11.6 million, EPS $1.51 per diluted common share outstanding.","evidence_excerpt":"per diluted common share outstanding, compared to $8.5 million or $1.10 per diluted common share outstanding in the same period of 2022. Sales for the fourth quarter 2023 were $101.5 million, 11.2% higher than 2022 fourth quarter sales of $91.2 million. “I am very pleased with our fourth quarter and full year 2023 results,” said R. Jeffrey Bailly, Chairman & CEO.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/914156/000117184324000970/0001171843-24-000970-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$101.5 million"},{"label":"Net income","value":"$11.6 million"},{"label":"EPS","value":"$1.51 per diluted common share outstanding"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"efcc0a477abb6390c79d06ad25f196843b34a292","claim":"UFP TECHNOLOGIES INC reported year ended December 31, 2023 results: revenue $400.1 million, net income $44.9 million, EPS $5.83 per diluted common share outstanding.","evidence_excerpt":"share outstanding for its year ended December 31, 2023, compared to net income of $41.8 million or $5.45 per diluted common share outstanding for 2022. Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million. For its fourth quarter ended December 31, 2023, the Company reported net income of $11.6 million or $1.51 per diluted common","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/914156/000117184324000970/0001171843-24-000970-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 31, 2023"},{"label":"Revenue","value":"$400.1 million"},{"label":"Net income","value":"$44.9 million"},{"label":"EPS","value":"$5.83 per diluted common share outstanding"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}